These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 31262236)

  • 21. Sample restrictions and the elicitation of a constant willingness to pay per quality adjusted life year.
    Nielsen JS; Gyrd-Hansen D; Kjaer T
    Health Econ; 2021 May; 30(5):923-931. PubMed ID: 33569834
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of factors affecting willingness to pay for cardiovascular disease-related medical services.
    Yasunaga H; Ide H; Imamura T; Ohe K
    Int Heart J; 2006 Mar; 47(2):273-86. PubMed ID: 16607054
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Willingness to pay for health care services in common cold, retinal detachment, and myocardiac infarction: an internet survey in Japan.
    Yasunaga H; Ide H; Imamura T; Ohe K
    BMC Health Serv Res; 2006 Feb; 6():12. PubMed ID: 16504017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Value of a QALY and VSI estimated with the chained approach.
    Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
    Eur J Health Econ; 2019 Sep; 20(7):1063-1077. PubMed ID: 31172400
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimating a WTP-based value of a QALY: the 'chained' approach.
    Robinson A; Gyrd-Hansen D; Bacon P; Baker R; Pennington M; Donaldson C;
    Soc Sci Med; 2013 Sep; 92():92-104. PubMed ID: 23849283
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring the willingness to pay for a quality-adjusted life-year in the state of Penang, Malaysia.
    Shafie AA; Lim YW; Chua GN; Hassali MA
    Clinicoecon Outcomes Res; 2014; 6():473-81. PubMed ID: 25364267
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Estimating the range of incremental cost-effectiveness thresholds for healthcare based on willingness to pay and GDP per capita: A systematic review.
    Iino H; Hashiguchi M; Hori S
    PLoS One; 2022; 17(4):e0266934. PubMed ID: 35421181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. How you ask is what you get: Framing effects in willingness-to-pay for a QALY.
    Ahlert M; Breyer F; Schwettmann L
    Soc Sci Med; 2016 Feb; 150():40-8. PubMed ID: 26730880
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Willingness to pay for a quality-adjusted life year: an evaluation of attitudes towards risk and preferences.
    Martín-Fernández J; Polentinos-Castro E; del Cura-González MI; Ariza-Cardiel G; Abraira V; Gil-LaCruz AI; García-Pérez S
    BMC Health Serv Res; 2014 Jul; 14():287. PubMed ID: 24989615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Determination of Cost-Effectiveness Threshold for Health Care Interventions in Malaysia.
    Lim YW; Shafie AA; Chua GN; Ahmad Hassali MA
    Value Health; 2017 Sep; 20(8):1131-1138. PubMed ID: 28964445
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ex post and ex ante willingness to pay (WTP) for the ICT Malaria Pf/Pv test kit in Myanmar.
    Cho-Min-Naing ; Lertmaharit S; Kamol-Ratanakul P; Saul AJ
    Southeast Asian J Trop Med Public Health; 2000 Mar; 31(1):104-11. PubMed ID: 11023075
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The value of a QALY: individual willingness to pay for health gains under risk.
    Bobinac A; van Exel J; Rutten FF; Brouwer WB
    Pharmacoeconomics; 2014 Jan; 32(1):75-86. PubMed ID: 24293198
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The impact of the design of payment scales on the willingness to pay for health gains.
    Soeteman L; van Exel J; Bobinac A
    Eur J Health Econ; 2017 Jul; 18(6):743-760. PubMed ID: 27623946
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is there a kink in consumers' threshold value for cost-effectiveness in health care?
    O'Brien BJ; Gertsen K; Willan AR; Faulkner LA
    Health Econ; 2002 Mar; 11(2):175-80. PubMed ID: 11921315
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Willingness-to-Pay for One Quality-Adjusted Life-Year: A Population-Based Study from Iran.
    Lankarani KB; Ghahramani S; Moradi N; Shahraki HR; Lotfi F; Honarvar B
    Appl Health Econ Health Policy; 2018 Dec; 16(6):837-846. PubMed ID: 30123949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparing WTP values of different types of QALY gain elicited from the general public.
    Pennington M; Baker R; Brouwer W; Mason H; Hansen DG; Robinson A; Donaldson C;
    Health Econ; 2015 Mar; 24(3):280-93. PubMed ID: 25625510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quality-adjusted life years was a poor predictor of women's willingness to pay in acute and chronic conditions: results of a survey.
    Franic DM; Pathak DS; Gafni A
    J Clin Epidemiol; 2005 Mar; 58(3):291-303. PubMed ID: 15718119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Willingness-to-pay stated preferences for 8 health-related quality-of-life domains in psoriatic arthritis: a pilot study.
    Hu SW; Holt EW; Husni ME; Qureshi AA
    Semin Arthritis Rheum; 2010 Apr; 39(5):384-97. PubMed ID: 19095293
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Willingness to pay for one quality-adjusted life year in Iran.
    Moradi N; Rashidian A; Nosratnejad S; Olyaeemanesh A; Zanganeh M; Zarei L
    Cost Eff Resour Alloc; 2019; 17():4. PubMed ID: 30867654
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Measuring the end-of-life premium in cancer using individual ex ante willingness to pay.
    Olofsson S; Gerdtham UG; Hultkrantz L; Persson U
    Eur J Health Econ; 2018 Jul; 19(6):807-820. PubMed ID: 28803265
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.